CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)		12 Months Ended
		Sep. 30, 2025	Sep. 30, 2024
Income Statement [Abstract]
Revenue		$ 363,726
Cost of revenue		(87,602)
Gross profit		276,124
General and administrative expenses		(716,944)	(814,725)
Research and development expenses		(171,038)	(172,584)
Operating losses		(611,858)	(987,309)
Other income/(expense)		(17,713)	6,332
Interest expense		(1,238)	(14,293)
Loss before income taxes		(630,809)	(995,270)
Income taxes expense
Net losses		(630,809)	(995,270)
Other comprehensive income
Foreign currency translation adjustment		(5,088)
Total comprehensive loss		$ (635,897)	$ (995,270)
Loss per share
Earnings Per Share, Diluted		$ (0.03)	$ (0.05)
Earnings Per Share, Diluted		$ (0.03)	$ (0.05)
Weighted average number of ordinary shares outstanding*
Weighted Average Number of Shares Outstanding, Basic	[1]	20,181,657	20,000,000
Weighted Average Number of Shares Outstanding, Diluted	[1]	20,181,657	20,000,000

[1] The shares are presented on a retrospective base to reflect the Company’s reverse stock split effected on October 8, 2024.